NDRA insider buying & filings

NDRAENDRA Life Sciences Inc.

NasdaqCM · Healthcare · $5.65M

$4.45

-0.22% · Jul 29

9 insider filings on record.
None of them an open-market buy in the last year.

Last Form 4 Jan 23 · scanned 12m ago

Price · 1Y · dailyNo open-market activity in range

▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained

AI brief · from the filings on this pagePro

The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.

Market cap

$5.65M

Float

1.2M

94% public

Short % float

Pro

Institutional stakes

▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing

1 filingnewest first

13D/ADigiandomenico Anthony9.9%Jun 29

The record

newest first

DateTypeInsiderOf stakeShares @ priceValue

Jan 23GRANTHarsh MichaelDirectordirect60,324 sh—

Jan 23GRANTJacroux RichardChief Financial Officerdirect20,000 sh—

Jan 23GRANTTokman Alexander YChief Executive Officerdirect75,000 sh—

Jan 23GRANTDigiandomenico AnthonyDirectordirect60,324 sh—

Jan 23GRANTBasenese LouDirectordirect60,324 sh—

The file stays open

▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice